@inbook{e48435fd081c4f7b84687f6a417f617b,
title = "The Potential of Psychedelics for End of Life and Palliative Care",
abstract = "End of life and palliative care has improved in recent decades but the psychopharmacological options available to clinicians and patients in these contexts remain limited. In particular, psychological factors such as depression, existential distress, and well-being remain challenging to address with current medications. Here, we review recent research on the use of psychedelics in clinical settings with a particular focus on patients with life-threatening diagnoses. We propose that psychedelics may provide clinicians with an additional psychopharmacological treatment in the context of end of life and palliative care.",
keywords = "End of Life, Palliative care, Psilocybin, Psychedelics, Psychiatry",
author = "Yaden, {David B.} and Nayak, {Sandeep M.} and Natalie Gukasyan and Anderson, {Brian T.} and Griffiths, {Roland R.}",
note = "Funding Information: Acknowledgements Funding: Support for Drs. D. Yaden, S. Nayak, N. Gukasyan, and R. Griffiths through the Johns Hopkins Center for Psychedelic and Consciousness Research was provided by Tim Ferriss, Matt Mullenweg, Blake Mycoskie, Craig Nerenberg, and the Steven and Alexandra Cohen Foundation as well as a grant from the Y.C. Ho/Helen and Michael Chiang Foundation. Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.",
year = "2022",
doi = "10.1007/7854_2021_278",
language = "English (US)",
series = "Current Topics in Behavioral Neurosciences",
publisher = "Springer Science and Business Media Deutschland GmbH",
pages = "169--184",
booktitle = "Current Topics in Behavioral Neurosciences",
address = "Germany",
}